Albuminuria and CKD: Tackling the silent marker with SGLT2 inhibitors
91 views
Streamed on 18 Jun, 2025, 07:00 PM
ABOUT THIS SESSION
Chronic kidney disease (CKD) is often a silent but progressive condition, with albuminuria serving as a key marker of kidney damage and cardiovascular risk. Recent advances in nephrology have highlighted the crucial role of sodium-glucose cotransporter-2 (SGLT2) inhibitors in slowing CKD progression and reducing albuminuria.
FACULTY
Dr. Sangeeth Kumar
Dr. Sangeeth Kumar, MBBS, MD (Medicine), DM (Nephrology), DrNB (Nephrology), SCE (Nephrology - MRCP-UK) is the Consultant Nephrologist at TMM Hospital, Kerala.
Latest Archive Videos
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
